X4 Pharmaceuticals, Inc.

XFORNASDAQHealthcare● Active

$3.71

$-0.12(-3.13%)

Market Cap$349926072

P/E Ratio—

52W High$4.83

52W Low$1.35

Avg Volume423K

Open$3.91

Beta0.37

Employees Ownership Insider Trades

X4 Pharmaceuticals, Inc. (XFOR) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · XFOR · as of Mar 17, 2026

Latest filing snapshot

-98-68.53%vs prior year

X4 Pharmaceuticals, Inc. (XFOR) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

-98

Growth % (1Y)

-68.53%

Revenue / Employee

$780.3K

Net Income / Employee

$-1.76M

Market Cap

$350M

XFOR Employee Count

2017 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-17	2025-12-31	45	-98	-68.53%
2025-03-26	2024-12-31	143	+50	+53.76%
2024-03-21	2023-12-31	93	+23	+32.86%
2023-03-21	2022-12-31	70	-13	-15.66%
2022-03-17	2021-12-31	83	+11	+15.28%
2021-03-19	2020-12-31	72	+14	+24.14%
2020-03-12	2019-12-31	58	+43	+286.67%
2019-03-11	2018-12-31	15	-25	-62.50%
2018-03-09	2017-12-31	40	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

KPTI

Karyopharm Therapeutics Inc.

Mersana Therapeutics, Inc.

102$145M #4

ALGS

Aligos Therapeutics, Inc.

70$31M #5

KZR

Kezar Life Sciences, Inc.

55$54M #6

XFOR

X4 Pharmaceuticals, Inc.YOU

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · XFOR peer comparison

About XFOR employees

XFOR Employees · Headcount

X4 Pharmaceuticals, Inc. (XFOR) employee data is sourced from the annual SEC 10-K filing. As of 2025, X4 Pharmaceuticals, Inc. had 45 full-time employees globally. Full-time employees only. Global consolidated headcount.

X4 Pharmaceuticals, Inc. employs 45 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $780,289, reflecting the company's operational efficiency.

X4 Pharmaceuticals, Inc.'s workforce decreased by 98 (68.53%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

X4 Pharmaceuticals, Inc.'s revenue per employee of $780,289 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

XFOR Employees · 5 questions

As of the latest SEC 10-K filing (2025), X4 Pharmaceuticals, Inc. had 45 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

X4 Pharmaceuticals, Inc. employee counthow many employees does X4 Pharmaceuticals, Inc. haveXFOR total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-17